Our Open Letter to PBAC & Decision Makers

Our call for Dupixent/Dupilumab to urgently listed on the PBS

Archive for November 2020

Our Open Letter to PBAC & Decision Makers

Eczema Support Australia has issued an Open Letter calling on all those responsible for medicines access to list Dupixent on the PBS as a matter of urgency. HERE IS OUR OPEN LETTER: Open Letter to the Pharmaceutical Benefits Advisory Committee and those who make decisions about medicines access in Australia You have never met us,…

Read More